Accounts Receivable & Denial Management for Infectious Disease Practices

Denial management is the process of identifying, categorizing, correcting, appealing, and tracking claims that a payer has not paid as expected. For infectious disease practices, denials may involve drug and administration coding, missing authorization, medical versus pharmacy benefit rules, under-documented consults, or claim details. Effective management also examines root causes so recurring denial patterns can be addressed by clinical, coding, billing, and front-office teams.

Denial management helps an infectious disease practice understand why claims are rejected or unpaid and where corrective action is needed. Reviews can separate issues involving documentation, coding, authorization, benefit classification, drug billing, administration charges, or payer requirements. Appeals can then be supported with relevant clinical documentation and claim information, while recurring patterns are shared with the teams responsible for preventing avoidable denials.

Relevant claims may include E/M services, hospital consults, infusion administration, drug claims, OPAT-related services, specialty drugs, and complex outpatient visits. Review may address claim submission, rejection clearing, payment reconciliation, aging follow-up, authorization status, coding details, units, NDC information, and payer contract compliance. The appropriate review depends on the service lines, systems, and financial questions a practice is evaluating.

Accounts receivable recovery organizes unpaid or aging claims by payer, service type, and balance, then documents follow-up activity until each claim is resolved. In infectious disease, particular attention may be appropriate for drug, infusion, hospital consult, and complex outpatient claims. The review can also identify why claims stalled, whether payment was incomplete, and whether workflow changes could reduce future delays or uncollected balances.

Yes. Payment reconciliation compares received payments with expected reimbursement for drug, administration, and E/M claims. The review can flag short-pays, incorrect fee schedule application, unit mismatches, NDC mismatches, and other discrepancies. Underpayments may then be disputed and tracked toward recovery. Contract and coverage agreement reviews can also help identify situations where payer payments do not align with documented terms.

Eligibility and authorization support can include verifying benefits, determining whether therapy falls under the medical or pharmacy benefit, and managing prior authorizations for infusions, OPAT courses, and specialty drugs. Authorization status is tracked so the practice can understand outstanding requests and financial exposure. This is especially relevant when drug acquisition and infusion administration create substantial reimbursement risk.

Claims management and overflow support can be structured around the practice’s existing systems and workflows. Areas may include charge entry, coding review, claim scrubbing, submission, rejection clearing, and follow-up for E/M, infusion, and drug claims. Support can be considered when internal teams face a claims backlog, need additional workflow capacity, or want a clearer view of recurring revenue-cycle issues.

A useful review may include payer performance, denial categories, aging A/R, payment trends, documentation and coding workflows, eligibility and authorization processes, drug and infusion billing, charge capture, contract terms, and hospital coverage arrangements. Practices should use their own operational and financial information rather than relying on generalized rates or margins. The goal is to trace each gap to a practical cause and prioritize corrective action.